Visionary Ventures

Visionary Ventures is a venture capital fund investing in life sciences, ophthalmology, and medical aesthetics. They focus on early and late-stage investments, from Series A rounds through commercialization, with a target investment range of $5M to $15M. Their unique approach leverages partnerships with Key Opinion Leaders (KOLs) to enhance investment insights and reduce risk.

Visionary Ventures favicon
Founded 2016 ยท Venture Capital
Newport Beach (United States)
Investment Stages
Series A
Series B
Markets
Ophthalmology
Medical Aesthetics
Life Sciences
Portfolio Companies

Aurion Biotech, Centricity Vision, CorneaGen, IanTech, IanTrek, Inc., ONL Therapeutics, Orasis, Pelage Pharmaceuticals, Re-Vana Therapeutics, RxSight, Surface Pharmaceuticals, Sydnexis, Tarsus Pharmaceuticals, Tear Film Innovations, TearClear

Share this page

Want more backlinks, traffic, and startup visibility?

Get your startup listed in 100+ directories automatically. Perfect for SaaS, AI, and tech startups.

Submit Your Startup